NovoCure Limited NVCR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • JE • USD

SharesGrow Score

51/100

3/7 Pass

SharesGrow Intrinsic Value

Es gab 50 kürzliche Insider-Transaktionen für NovoCure Limited (NVCR), darunter 26 Käufe und 21 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $9.91M und die gesamten Insider-Verkäufe auf $2.01M.

Bedeutende Insider mit kürzlicher Aktivität umfassen Paravasthu Mukund, Weinberg Uri, Cordova Ashley. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.

Insider-Transaktionen — NVCR

Datum	Name	Funktion	Transaktionsart	Aktien	Ø Preis	Wert	Gehaltene Aktien
2026-03-05	Paravasthu Mukund	Chief Operating Officer	Informierter Verkauf	43,246	$13.77	$595.67K	72,832
2026-03-04	Weinberg Uri	Chf Medical and Innovation Ofr	Informierter Verkauf	6,412	$13.31	$85.31K	267,190
2026-03-04	Cordova Ashley	Former Chief Executive Officer	RSU-Steuereinbehalt	17,638	$13.30	$234.59K	422,570
2026-03-04	Leonard Frank X	Chief Executive Officer	Informierter Verkauf	5,607	$13.31	$74.6K	493,793
2026-03-04	Puri Michal Nath	Chief Human Resources Officer	Informierter Verkauf	1,100	$13.31	$14.64K	201,322
2026-03-04	Leupin Nicolas	Former Chief Medical Officer	Informierter Verkauf	1,100	$13.31	$14.64K	102,979
2026-03-04	Paravasthu Mukund	Chief Operating Officer	Informierter Verkauf	5,377	$13.31	$71.54K	116,078
2026-03-04	Brackmann Christoph	Chief Financial Officer	Informierter Verkauf	6,412	$13.31	$85.31K	182,842
2026-03-03	Doyle William F	Executive Chairman	RSU-Zuteilung	200,000	-	-	200,000
2026-03-03	Weinberg Uri	Chf Medical and Innovation Ofr	RSU-Zuteilung	73,340	$13.30	$975.42K	73,340
2026-03-03	Leonard Frank X	Chief Executive Officer	RSU-Zuteilung	216,388	$13.30	$2.88M	216,388
2026-03-03	Ben Arye Barak	General Counsel	RSU-Zuteilung	73,340	$13.30	$975.42K	73,340
2026-03-03	Puri Michal Nath	Chief Human Resources Officer	RSU-Zuteilung	58,672	$13.30	$780.34K	58,672
2026-03-03	Paravasthu Mukund	Chief Operating Officer	RSU-Zuteilung	7,518	$13.30	$99.99K	7,518
2026-03-03	Brackmann Christoph	Chief Financial Officer	RSU-Zuteilung	80,674	$13.30	$1.07M	80,674
2026-03-02	Weinberg Uri	Chf Medical and Innovation Ofr	Informierter Verkauf	3,272	$13.33	$43.61K	223,477
2026-03-02	Cordova Ashley	Former Chief Executive Officer	RSU-Steuereinbehalt	7,228	$13.67	$98.81K	440,208
2026-03-02	Leonard Frank X	Chief Executive Officer	Informierter Verkauf	7,232	$13.49	$97.58K	349,400
2026-02-28	Weinberg Uri	Chf Medical and Innovation Ofr	RSU-Zuteilung	12,992	-	-	226,749
2026-02-28	Cordova Ashley	Former Chief Executive Officer	RSU-Zuteilung	23,818	-	-	449,846
2026-02-28	Leonard Frank X	Chief Executive Officer	RSU-Zuteilung	18,621	-	-	356,632
2026-02-28	Ben Arye Barak	General Counsel	RSU-Zuteilung	17,755	-	-	192,328
2026-02-27	Weinberg Uri	Chf Medical and Innovation Ofr	Informierter Verkauf	7,461	$13.84	$103.26K	213,757
2026-02-27	Cordova Ashley	Former Chief Executive Officer	RSU-Steuereinbehalt	11,541	$13.75	$158.69K	426,028
2026-02-27	Leonard Frank X	Chief Executive Officer	Informierter Verkauf	9,734	$13.66	$133K	338,011
2026-02-27	Puri Michal Nath	Chief Human Resources Officer	Informierter Verkauf	1,441	$13.66	$19.69K	162,322
2026-01-11	Paravasthu Mukund	Chief Operating Officer	RSU-Steuereinbehalt	2,133	$14.35	$30.61K	78,306
2025-12-31	Danziger Asaf	Officer	Unbekannt	-	-	-	-
2025-12-31	Ben Arye Barak	Officer	Unbekannt	-	-	-	-
2025-12-31	Puri Michal Nath	Officer	Unbekannt	-	-	-	-
2025-11-04	Paravasthu Mukund	Chief Operating Officer	RSU-Steuereinbehalt	2,949	$12.23	$36.07K	80,439
2025-11-04	Brackmann Christoph	Chief Financial Officer	RSU-Steuereinbehalt	7,033	$12.23	$86.01K	134,117
2025-11-01	Leonard Frank X	EVP, Pres., Novocure Oncology	RSU-Steuereinbehalt	966	$12.81	$12.37K	347,745
2025-11-01	Paravasthu Mukund	Chief Operating Officer	RSU-Steuereinbehalt	168	$12.81	$2.15K	83,388
2025-10-31	Puri Michal Nath	Chief Human Resources Officer	RSU-Steuereinbehalt	752	$12.82	$9.64K	163,762
2025-09-05	Cordova Ashley	Chief Executive Officer	Informierter Kauf	81,550	$12.22	$996.86K	437,569
2025-07-29	Brackmann Christoph	Chief Financial Officer	Informierter Kauf	10,000	$11.63	$116.3K	131,150
2025-06-30	Danziger Asaf	Director	RSU-Zuteilung	833	$15.13	$12.6K	416,473
2025-06-30	Cordova Ashley	Chief Executive Officer	RSU-Zuteilung	833	$15.13	$12.6K	356,019
2025-06-30	Leonard Frank X	EVP, Pres., Novocure Oncology	RSU-Zuteilung	833	$15.13	$12.6K	348,711
2025-06-30	Ben Arye Barak	General Counsel	RSU-Zuteilung	769	$15.13	$11.63K	174,465
2025-06-30	Puri Michal Nath	Chief Human Resources Officer	RSU-Zuteilung	833	$15.13	$12.6K	164,514
2025-06-04	Hilleman Jeryl L	Director	RSU-Zuteilung	16,697	$16.72	$279.17K	16,697
2025-06-04	Leung Gabriel	Director	RSU-Zuteilung	16,697	$16.72	$279.17K	16,697
2025-06-04	Hung David	Director	RSU-Zuteilung	16,697	$16.72	$279.17K	16,697
2025-06-04	Vernon W Anthony	Director	RSU-Zuteilung	16,697	$16.72	$279.17K	16,697
2025-06-04	Scannell Timothy J	Director	RSU-Zuteilung	16,697	$16.72	$279.17K	16,697
2025-06-04	Madden Martin J.	Director	RSU-Zuteilung	33,393	$16.72	$558.33K	33,393
2025-06-04	Leonard Frank X	EVP, Pres., Novocure Oncology	RSU-Zuteilung	179,426	-	-	347,878
2025-06-04	Ocean Allyson J	Director	RSU-Zuteilung	11,215	-	-	14,269

■ Informativ — Transaktion am offenen Markt (bedeutendste) ■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung ■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting ■ Neutral — Schenkung, Treuhand, Verfall